REFERENCES

1. Dame-Teixeira N, Do T, Deng D. The oral microbiome and us. Adv Exp Med Biol. 2025;1472:3-9.

2. Baker JL, Mark Welch JL, Kauffman KM, McLean JS, He X. The oral microbiome: diversity, biogeography and human health. Nat Rev Microbiol. 2024;22:89-104.

3. Arweiler NB, Netuschil L. The oral microbiota. Adv Exp Med Biol. 2016;902:45-60.

4. Wade WG. The oral microbiome in health and disease. Pharmacol Res. 2013;69:137-43.

5. Tuganbaev T, Yoshida K, Honda K. The effects of oral microbiota on health. Science. 2022;376:934-6.

6. Kleinstein SE, Nelson KE, Freire M. Inflammatory networks linking oral microbiome with systemic health and disease. J Dent Res. 2020;99:1131-9.

7. Peng X, Cheng L, You Y, et al. Oral microbiota in human systematic diseases. Int J Oral Sci. 2022;14:14.

8. Bosshardt DD. The periodontal pocket: pathogenesis, histopathology and consequences. Periodontol 2000. 2018;76:43-50.

9. Kunath BJ, De Rudder C, Laczny CC, Letellier E, Wilmes P. The oral-gut microbiome axis in health and disease. Nat Rev Microbiol. 2024;22:791-805.

10. Hernández-Cabanyero C, Vonaesch P. Ectopic colonization by oral bacteria as an emerging theme in health and disease. FEMS Microbiol Rev. 2024;48:fuae012.

11. Asikainen S, Alaluusua S. Bacteriology of dental infections. Eur Heart J. 1993;14 Suppl K:43-50.

12. Xie J, Li Q, Haesebrouck F, Van Hoecke L, Vandenbroucke RE. The tremendous biomedical potential of bacterial extracellular vesicles. Trends Biotechnol. 2022;40:1173-94.

13. Ho MY, Liu S, Xing B. Bacteria extracellular vesicle as nanopharmaceuticals for versatile biomedical potential. Nano Converg. 2024;11:28.

14. Moghaddam ZS, Dehghan A, Halimi S, et al. Bacterial extracellular vesicles: bridging pathogen biology and therapeutic innovation. Acta Biomater. 2025;200:1-20.

15. Toyofuku M, Schild S, Kaparakis-Liaskos M, Eberl L. Composition and functions of bacterial membrane vesicles. Nat Rev Microbiol. 2023;21:415-30.

16. Effah CY, Ding X, Drokow EK, Li X, Tong R, Sun T. Bacteria-derived extracellular vesicles: endogenous roles, therapeutic potentials and their biomimetics for the treatment and prevention of sepsis. Front Immunol. 2024;15:1296061.

17. Yates AG, Pink RC, Erdbrügger U, et al. In sickness and in health: the functional role of extracellular vesicles in physiology and pathology in vivo: Part I: Health and Normal Physiology: Part I: Health and Normal Physiology. J Extracell Vesicles. 2022;11:e12151.

18. Yates AG, Pink RC, Erdbrügger U, et al. In sickness and in health: the functional role of extracellular vesicles in physiology and pathology in vivo: Part II: Pathology: Part II: Pathology. J Extracell Vesicles. 2022;11:e12190.

19. Kaparakis-Liaskos M, Ferrero RL. Immune modulation by bacterial outer membrane vesicles. Nat Rev Immunol. 2015;15:375-87.

20. Jeong GJ, Khan F, Tabassum N, Cho KJ, Kim YM. Bacterial extracellular vesicles: modulation of biofilm and virulence properties. Acta Biomater. 2024;178:13-23.

21. Xia X, Fang Y, Zhong J, Li F, Jiang L. Biomimetic strategies of cell membrane vesicles driven by pathogen-host interactions: novel insights into antimicrobial immunotherapy and infection prevention. Front Immunol. 2025;16:1681889.

22. Deng DK, Zhang JJ, Gan D, et al. Roles of extracellular vesicles in periodontal homeostasis and their therapeutic potential. J Nanobiotechnology. 2022;20:545.

23. Schwechheimer C, Kuehn MJ. Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions. Nat Rev Microbiol. 2015;13:605-19.

24. Costa TRD, Felisberto-Rodrigues C, Meir A, et al. Secretion systems in Gram-negative bacteria: structural and mechanistic insights. Nat Rev Microbiol. 2015;13:343-59.

25. Briaud P, Carroll RK. Extracellular vesicle biogenesis and functions in Gram-positive bacteria. Infect Immun. 2020;88:e00433-20.

26. Welsh JA, Goberdhan DCI, O’Driscoll L, et al.; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404.

27. Zhang H, Lin Y, Li S, et al. Effects of bacterial extracellular vesicles derived from oral and gastrointestinal pathogens on systemic diseases. Microbiol Res. 2024;285:127788.

28. Ñahui Palomino RA, Vanpouille C, Costantini PE, Margolis L. Microbiota-host communications: bacterial extracellular vesicles as a common language. PLoS Pathog. 2021;17:e1009508.

29. Gan Y, Zhao G, Wang Z, Zhang X, Wu MX, Lu M. Bacterial membrane vesicles: physiological roles, infection immunology, and applications. Adv Sci. 2023;10:e2301357.

30. Toyofuku M, Nomura N, Eberl L. Types and origins of bacterial membrane vesicles. Nat Rev Microbiol. 2019;17:13-24.

31. Furuyama N, Sircili MP. Outer membrane vesicles (OMVs) produced by Gram-negative bacteria: structure, functions, biogenesis, and vaccine application. Biomed Res Int. 2021;2021:1490732.

32. Zhang Z, Liu D, Liu S, Zhang S, Pan Y. The role of Porphyromonas gingivalis outer membrane vesicles in periodontal disease and related systemic diseases. Front Cell Infect Microbiol. 2020;10:585917.

33. Ahmadi P, Mahmoudi M, Kheder RK, et al. Impacts of Porphyromonas gingivalis periodontitis on rheumatoid arthritis autoimmunity. Int Immunopharmacol. 2023;118:109936.

34. Zhang L, Leng XX, Qi J, et al. The adhesin RadD enhances Fusobacterium nucleatum tumour colonization and colorectal carcinogenesis. Nat Microbiol. 2024;9:2292-307.

35. Zhang L, Zhang D, Liu C, et al. Outer membrane vesicles derived from Fusobacterium nucleatum trigger periodontitis through host overimmunity. Adv Sci. 2024;11:e2400882.

36. Kato S, Kowashi Y, Demuth DR. Outer membrane-like vesicles secreted by Actinobacillus actinomycetemcomitans are enriched in leukotoxin. Microb Pathog. 2002;32:1-13.

37. Rompikuntal PK, Thay B, Khan MK, et al. Perinuclear localization of internalized outer membrane vesicles carrying active cytolethal distending toxin from Aggregatibacter actinomycetemcomitans. Infect Immun. 2012;80:31-42.

38. Rosen G, Naor R, Rahamim E, Yishai R, Sela MN. Proteases of Treponema denticola outer sheath and extracellular vesicles. Infect Immun. 1995;63:3973-9.

39. Abiko Y, Nagano K, Yoshida Y, Yoshimura F. Characterization of Treponema denticola mutants defective in the major antigenic proteins, Msp and TmpC. PLoS One. 2014;9:e113565.

40. Lim Y, Kim HY, Han D, Choi BK. Proteome and immune responses of extracellular vesicles derived from macrophages infected with the periodontal pathogen Tannerella forsythia. J Extracell Vesicles. 2023;12:e12381.

41. Kim HY, Lim Y, An SJ, Choi BK. Characterization and immunostimulatory activity of extracellular vesicles from Filifactor alocis. Mol Oral Microbiol. 2020;35:1-9.

42. Nakamura T, Iwabuchi Y, Hirayama S, et al. Roles of membrane vesicles from Streptococcus mutans for the induction of antibodies to glucosyltransferase in mucosal immunity. Microb Pathog. 2020;149:104260.

43. Peri F, Granucci F, Weiss J. “Endotoxin, TLR4 signaling and beyond”. Mol Immunol. 2015;63:125-6.

44. Roier S, Zingl FG, Cakar F, et al. A novel mechanism for the biogenesis of outer membrane vesicles in Gram-negative bacteria. Nat Commun. 2016;7:10515.

45. Gui MJ, Dashper SG, Slakeski N, Chen YY, Reynolds EC. Spheres of influence: Porphyromonas gingivalis outer membrane vesicles. Mol Oral Microbiol. 2016;31:365-78.

46. Cecil JD, O’Brien-Simpson NM, Lenzo JC, et al. Differential responses of pattern recognition receptors to outer membrane vesicles of three periodontal pathogens. PLoS One. 2016;11:e0151967.

47. Wang J, Liu C, Cutler J, Ivanovski S, Lee RS, Han P. Microbial- and host immune cell-derived extracellular vesicles in the pathogenesis and therapy of periodontitis: a narrative review. J Periodontal Res. 2024;59:1115-29.

48. Choi JW, Kim SC, Hong SH, Lee HJ. Secretable small RNAs via outer membrane vesicles in periodontal pathogens. J Dent Res. 2017;96:458-66.

49. Villanueva-Carmona T, Cedó L, Madeira A, et al. SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression. Cell Metab. 2023;35:601-19.e10.

50. Luo R, Chang Y, Liang H, et al. Interactions between extracellular vesicles and microbiome in human diseases: new therapeutic opportunities. Imeta. 2023;2:e86.

51. Jing L, Wang HY, Zhang N, et al. Critical roles of extracellular vesicles in periodontal disease and regeneration. Stem Cells Transl Med. 2025;14:szae092.

52. Mahendrarajan V, Lazarus HPS, Muthukaliannan GK, Varghese S, Easwaran N. Membrane vesicles from Red Complex bacteria: key players in oral pathogenesis, immune disruption, systemic diseases, and therapeutic insights. Front Oral Health. 2025;6:1607931.

53. Uemura Y, Hiroshima Y, Tada A, et al. Porphyromonas gingivalis outer membrane vesicles stimulate gingival epithelial cells to induce pro-inflammatory cytokines via the MAPK and STING pathways. Biomedicines. 2022;10:2643.

54. Friedrich V, Gruber C, Nimeth I, et al. Outer membrane vesicles of Tannerella forsythia: biogenesis, composition, and virulence. Mol Oral Microbiol. 2015;30:451-73.

55. Zhao Y, Chen J, Tian Y, Huang H, Zhao F, Deng X. Treponema denticola major surface protein (Msp): a key player in periodontal pathogenicity and immune evasion. Arch Microbiol. 2025;207:36.

56. Chen G, Sun Q, Cai Q, Zhou H. Outer membrane vesicles from Fusobacterium nucleatum switch M0-like macrophages toward the M1 phenotype to destroy periodontal tissues in mice. Front Microbiol. 2022;13:815638.

57. Zhang R, Li G, Wu Y, Wang X, Luan Q. Pathogenic mechanisms and potential applications of extracellular vesicles from periodontal pathogens in periodontitis. Front Immunol. 2024;15:1513983.

58. Song G, Li M, Zhou B, Qi H, Guo J. Streptococcus mutans outer membrane vesicles affect inflammasome activation and the glycolysis of macrophages. Microb Pathog. 2024;196:106994.

59. Rainey K, Michalek SM, Wen ZT, Wu H. Glycosyltransferase-mediated biofilm matrix dynamics and virulence of Streptococcus mutans. Appl Environ Microbiol. 2019;85:e02247-18.

60. Cui G, Li P, Wu R, Lin H. Streptococcus mutans membrane vesicles inhibit the biofilm formation of Streptococcus gordonii and Streptococcus sanguinis. AMB Express. 2022;12:154.

61. Wu R, Tao Y, Cao Y, Zhou Y, Lin H. Streptococcus mutans membrane vesicles harboring glucosyltransferases augment Candida albicans biofilm development. Front Microbiol. 2020;11:581184.

62. Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6:92.

63. Liu D, Liu S, Liu J, Miao L, Zhang S, Pan Y. sRNA23392 packaged by Porphyromonas gingivalis outer membrane vesicles promotes oral squamous cell carcinomas migration and invasion by targeting desmocollin-2. Mol Oral Microbiol. 2021;36:182-91.

64. Zeng Y, Wang Y, Shi X, et al. Porphyromonas gingivalis outer membrane vesicles augments proliferation and metastasis of oral squamous cell carcinoma cells. BMC Oral Health. 2025;25:701.

65. Chen Q, Pang X, Liu K, et al. Porphyromonas gingivalis outer membrane vesicles promote oral tumorigenesis through suppressing innate immune surveillance. Microbiol Res. 2025;301:128296.

66. Yan L, Wu F, Jiao J, et al. Stomatobaculum longum-derived extracellular vesicles enhance oral squamous cell carcinoma malignancy through BRCA1/EXO1/TP53BP1 modulation. Int J Nanomedicine. 2025;20:6659-74.

67. Chen G, Gao C, Jiang S, et al. Fusobacterium nucleatum outer membrane vesicles activate autophagy to promote oral cancer metastasis. J Adv Res. 2024;56:167-79.

68. Metsäniitty M, Hasnat S, Öhman C, et al. Extracellular vesicles from Aggregatibacter actinomycetemcomitans exhibit potential antitumorigenic effects in oral cancer: a comparative in vitro study. Arch Microbiol. 2024;206:244.

69. Ha JY, Choi SY, Kim SJ, Seog KJ, Hong SH, Lee HJ. Transcriptome analysis of HNSCC by Aggregatibacter actinomycetemcomitans extracellular vesicles. Oral Dis. 2025;31:1165-77.

70. Suárez LJ, Arboleda S, Angelov N, Arce RM. Oral versus gastrointestinal mucosal immune niches in homeostasis and allostasis. Front Immunol. 2021;12:705206.

71. Liu S, Butler CA, Ayton S, Reynolds EC, Dashper SG. Porphyromonas gingivalis and the pathogenesis of Alzheimer’s disease. Crit Rev Microbiol. 2024;50:127-37.

72. Qiu Y, Zhao Y, He G, Yang D. Porphyromonas gingivalis and its outer membrane vesicles induce neuroinflammation in mice through distinct mechanisms. Immun Inflamm Dis. 2025;13:e70135.

73. Dominy SS, Lynch C, Ermini F, et al. Porphyromonas gingivalis in Alzheimer’s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019;5:eaau3333.

74. Gong T, Chen Q, Mao H, et al. Outer membrane vesicles of Porphyromonas gingivalis trigger NLRP3 inflammasome and induce neuroinflammation, tau phosphorylation, and memory dysfunction in mice. Front Cell Infect Microbiol. 2022;12:925435.

75. Yoshida K, Yoshida K, Seyama M, et al. Porphyromonas gingivalis outer membrane vesicles in cerebral ventricles activate microglia in mice. Oral Dis. 2023;29:3688-97.

76. Inoue E, Minatozaki S, Shimizu S, et al. Human β-defensin 3 inhibition of P. gingivalis LPS-induced IL-1β production by BV-2 microglia through suppression of cathepsins B and L. Cells. 2024;13:283.

77. Pritchard AB, Fabian Z, Lawrence CL, Morton G, Crean S, Alder JE. An investigation into the effects of outer membrane vesicles and lipopolysaccharide of Porphyromonas gingivalis on blood-brain barrier integrity, permeability, and disruption of scaffolding proteins in a human in vitro model. J Alzheimers Dis. 2022;86:343-64.

78. Ha JY, Choi SY, Lee JH, Hong SH, Lee HJ. Delivery of periodontopathogenic extracellular vesicles to brain monocytes and microglial IL-6 promotion by RNA cargo. Front Mol Biosci. 2020;7:596366.

79. Akhi R, Lavrinienko A, Hakula M, et al. Oral microbiota linking humoral response, periodontitis and atherosclerosis. J Clin Periodontol. 2025;52:1550-9.

80. Yang WW, Guo B, Jia WY, Jia Y. Porphyromonas gingivalis-derived outer membrane vesicles promote calcification of vascular smooth muscle cells through ERK1/2-RUNX2. FEBS Open Bio. 2016;6:1310-9.

81. Farrugia C, Stafford GP, Murdoch C. Porphyromonas gingivalis outer membrane vesicles increase vascular permeability. J Dent Res. 2020;99:1494-501.

82. Jia Y, Guo B, Yang W, Zhao Q, Jia W, Wu Y. Rho kinase mediates Porphyromonas gingivalis outer membrane vesicle-induced suppression of endothelial nitric oxide synthase through ERK1/2 and p38 MAPK. Arch Oral Biol. 2015;60:488-95.

83. Fleetwood AJ, Lee MKS, Singleton W, et al. Metabolic remodeling, inflammasome activation, and pyroptosis in macrophages stimulated by Porphyromonas gingivalis and its outer membrane vesicles. Front Cell Infect Microbiol. 2017;7:351.

84. Huang X, Xie M, Lu X, et al. The roles of periodontal bacteria in atherosclerosis. Int J Mol Sci. 2023;24:12861.

85. Kuramitsu HK, Qi M, Kang IC, Chen W. Role for periodontal bacteria in cardiovascular diseases. Ann Periodontol. 2001;6:41-7.

86. Shinjo T, Nishimura F. The bidirectional association between diabetes and periodontitis, from basic to clinical. Jpn Dent Sci Rev. 2024;60:15-21.

87. Seyama M, Yoshida K, Yoshida K, et al. Outer membrane vesicles of Porphyromonas gingivalis attenuate insulin sensitivity by delivering gingipains to the liver. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165731.

88. Huang S, Cao G, Dai D, et al. Porphyromonas gingivalis outer membrane vesicles exacerbate retinal microvascular endothelial cell dysfunction in diabetic retinopathy. Front Microbiol. 2023;14:1167160.

89. Engevik MA, Danhof HA, Ruan W, et al. Fusobacterium nucleatum secretes outer membrane vesicles and promotes intestinal inflammation. mBio. 2021;12:e02706-20.

90. Berbudi A, Khairani S, Tjahjadi AI. Interplay between insulin resistance and immune dysregulation in type 2 diabetes mellitus: implications for therapeutic interventions. Immunotargets Ther. 2025;14:359-82.

91. Sokolova MV, Schett G, Steffen U. Autoantibodies in rheumatoid arthritis: historical background and novel findings. Clin Rev Allergy Immunol. 2022;63:138-51.

92. Rak D, Kulloli AM, Shetty SK, et al. Correlation between rheumatoid arthritis and chronic periodontitis: a systematic review and meta-analysis. Minerva Dent Oral Sci. 2024;73:294-302.

93. Montgomery AB, Kopec J, Shrestha L, et al. Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis. Ann Rheum Dis. 2016;75:1255-61.

94. Gabarrini G, Palma Medina LM, Stobernack T, et al. There’s no place like OM: vesicular sorting and secretion of the peptidylarginine deiminase of Porphyromonas gingivalis. Virulence. 2018;9:456-64.

95. Yokota K, Sato K, Miyazaki T, et al. Characterization and function of tumor necrosis factor and interleukin-6-induced osteoclasts in rheumatoid arthritis. Arthritis Rheumatol. 2021;73:1145-54.

96. de Smit M, Westra J, Vissink A, Doornbos-van der Meer B, Brouwer E, van Winkelhoff AJ. Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study. Arthritis Res Ther. 2012;14:R222.

97. Reichert S, Haffner M, Keyßer G, et al. Detection of oral bacterial DNA in synovial fluid. J Clin Periodontol. 2013;40:591-8.

98. Hong M, Li Z, Liu H, et al. Fusobacterium nucleatum aggravates rheumatoid arthritis through FadA-containing outer membrane vesicles. Cell Host Microbe. 2023;31:798-810.e7.

99. Bobetsis YA, Graziani F, Gürsoy M, Madianos PN. Periodontal disease and adverse pregnancy outcomes. Periodontol 2000. 2020;83:154-74.

100. Butera A, Maiorani C, Morandini A, et al. Periodontitis in pregnant women: a possible link to adverse pregnancy outcomes. Healthcare. 2023;11:1372.

101. Tanai A, Okamura H. The role of extracellular vesicles throughout normal pregnancy and in relation to oral bacteria. J Oral Biosci. 2021;63:14-22.

102. Lara B, Loureiro I, Gliosca L, et al. Porphyromonas gingivalis outer membrane vesicles shape trophoblast cell metabolism impairing functions associated to adverse pregnancy outcome. J Cell Physiol. 2023;238:2679-91.

103. Aplin JD, Myers JE, Timms K, Westwood M. Tracking placental development in health and disease. Nat Rev Endocrinol. 2020;16:479-94.

104. Lara B, Sassot M, Calo G, et al. Extracellular vesicles of Porphyromonas gingivalis disrupt trophoblast cell interaction with vascular and immune cells in an in vitro model of early placentation. Life. 2023;13:1971.

105. Tanai A, Fukuhara Y, Eguchi T, et al. P. gingivalis-infected macrophage extracellular vesicles cause adverse pregnancy outcomes. J Dent Res. 2025;104:54-63.

106. Bradley AJ, Mashburn-Warren L, Blalock LC, Scarpetti F, Lauber CL. Porphyromonas gingivalis outer membrane vesicles alter cortical neurons and Tau phosphorylation in the embryonic mouse brain. PLoS One. 2025;20:e0310482.

107. Yu B, Wang CY. Osteoporosis and periodontal diseases - an update on their association and mechanistic links. Periodontol 2000. 2022;89:99-113.

108. Manjunath SH, Rakhewar P, Nahar P, Tambe V, Gabhane M, et al. Evaluation of the prevalence and severity of periodontal diseases between osteoporotic and nonosteoporotic subjects: a cross-sectional comparative study. J Contemp Dent Pract. 2019;20:1223-8.

109. Kim HY, Song MK, Lim Y, et al. Effects of extracellular vesicles derived from oral bacteria on osteoclast differentiation and activation. Sci Rep. 2022;12:14239.

110. Qiu Q, Yan X, Zhang Z, et al. Porphyromonas gingivalis extracellular vesicles exacerbated osteoporosis by disrupting osteoblast mitochondrial dynamics and inhibiting Cpt2-regulated fatty acid oxidation. J Nanobiotechnology. 2025;23:635.

111. Song MK, Kim HY, Choi BK, Kim HH. Filifactor alocis-derived extracellular vesicles inhibit osteogenesis through TLR2 signaling. Mol Oral Microbiol. 2020;35:202-10.

112. Kim HY, Song MK, Gho YS, Kim HH, Choi BK. Extracellular vesicles derived from the periodontal pathogen Filifactor alocis induce systemic bone loss through Toll-like receptor 2. J Extracell Vesicles. 2021;10:e12157.

113. He Y, Shiotsu N, Uchida-Fukuhara Y, et al. Outer membrane vesicles derived from Porphyromonas gingivalis induced cell death with disruption of tight junctions in human lung epithelial cells. Arch Oral Biol. 2020;118:104841.

114. Yoshida K, Yoshida K, Fujiwara N, et al. Extracellular vesicles of P. gingivalis-infected macrophages induce lung injury. Biochim Biophys Acta Mol Basis Dis. 2021;1867:166236.

115. Kim HY, Lim Y, Jang JS, et al. Extracellular vesicles from periodontal pathogens regulate hepatic steatosis via Toll-like receptor 2 and plasminogen activator inhibitor-1. J Extracell Vesicles. 2024;13:e12407.

116. Kim YG, Song HJ, Kim HJ, et al. Bacterial extracellular vesicles as potential promoting factors for oral lichen planus pathogenesis. Inflammation. 2025;48:1660-70.

117. Dong XH, Ho MH, Liu B, et al. Role of Porphyromonas gingivalis outer membrane vesicles in oral mucosal transmission of HIV. Sci Rep. 2018;8:8812.

118. Fu Y, Wang M, Teng R, Li A. Emerging roles of extracellular vesicles in the pathogenesis, diagnosis, and therapy of periodontitis. Biomedicines. 2025;13:2521.

119. Gegout PY, Mary B, Stutz C, et al. Porphyromonas gingivalis infection of oral keratinocytes drives the release of pro-inflammatory extracellular vesicles. Sci Rep. 2025;15:24704.

120. National Institute on Aging. Award R01AG088524: A Randomized, Double-Blind, Placebo-Controlled Study of LHP588 in Subjects with P. gingivalis-Positive Alzheimer’s Disease. 2025. Available from: https://taggs.hhs.gov/Detail/AwardDetail?arg_AwardNum=R01AG088524&arg_ProgOfficeCode=102&utm_source=chatgpt.com. [Last accessed on 29 May 2026].

121. Zhu X, Zou A, Zhao M, Hou J, Xianyu Y. Probiotic vesicles-implemented multifunctional nanotherapeutic approach for antibacterial, anti-inflammatory, and tissue regeneration in bacterial-infected oral ulcer healing. Adv Healthc Mater. 2025;14:e02050.

Extracellular Vesicles and Circulating Nucleic Acids
ISSN 2767-6641 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/